 | | PRD_002175 | | Name: | N,beta,beta-trimethyl-L-phenylalanyl-N-[(3S,4Z)-5-carboxy-2-methylhex-4-en-3-yl]-N,3-dimethyl-L-valinamide | | Formula: | C27 H43 N3 O4 | | Definition date: | 2016-07-27 | | Last modified: | 2016-07-27 |
|
 | | PRD_002237 | | Name: | (2R,4R)-4-{[(2-{(1R,3R)-1-(acetyloxy)-4-methyl-3-[methyl(N-{[(2S)-1-methylpiperidin-2-yl]carbonyl}-D-isoleucyl)amino]pentyl}-1,3-thiazol-4-yl)carbonyl]amino}-2-methyl-5-phenylpentanoic acid | | Formula: | C38 H57 N5 O7 S | | Definition date: | 2016-07-27 | | Last modified: | 2016-07-27 |
|
 | | PRD_002231 | | Name: | N~2~-{(4R,7S,10R,13R,16R,19S,24R)-19,24-diamino-16-(3-{[amino(iminio)methyl]amino}propyl)-7-(4-azaniumylbutyl)-10-[(1R)-1-hydroxyethyl]-13-[(1H-indol-3-yl)methyl]-6,9,12,15,18,23-hexaoxo-1,2-dithia-5,8,11,14,17,22-hexaazacyclopentacosane-4-carbonyl}-L-leucinamide | | Formula: | C43 H73 N15 O9 S2 | | Definition date: | 2016-06-01 | | Last modified: | 2016-06-01 |
|
 | | PRD_001260 | | Name: | PAMK PEPTIDE Inhibitor | | Formula: | C48 H80 N12 O15 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002162 | | Name: | N-[(4-carbamimidamidobutyl)carbamoyl]-L-seryl-N-[(2S)-5-{[amino(iminio)methyl]amino}-1-oxopentan-2-yl]-L-valinamide | | Formula: | C20 H41 N10 O5 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002222 | | Name: | N-(3-bromo-4-methoxybenzene-1-carbonyl)-beta-alanyl-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-threoninamide | | Formula: | C38 H53 Br N7 O11 P | | Definition date: | 2016-02-24 | | Last modified: | 2016-02-24 |
|
 | | PRD_002200 | | Name: | N-benzoyl-L-leucyl-L-leucine | | Formula: | C19 H28 N2 O4 | | Definition date: | 2016-02-17 | | Last modified: | 2016-02-17 |
|
 | | PRD_001259 | | Name: | acyclic trypsin inhibitor | | Formula: | C67 H108 N18 O19 S2 | | Definition date: | 2016-01-13 | | Last modified: | 2016-01-13 |
|
 | | PRD_002208 | | Formula: | C43 H66 N6 O8 | | Definition date: | 2015-12-16 | | Last modified: | 2015-12-16 |
|
 | | PRD_000929 | | Name: | N-acetyl-L-valyl-L-alpha-glutamyl-N-[(2S)-1-carboxy-3-hydroxypropan-2-yl]-L-isoleucinamide | | Formula: | C22 H38 N4 O9 | | Definition date: | 2015-12-02 | | Last modified: | 2015-12-02 |
|
 | | PRD_002182 | | Name: | [amino({3-[(3R,6R,9S,12R,15S,21R,24R,27S,30R,33S,36R,39S)-39-amino-36-(4-ammoniobutyl)-12,33-bis(2-carboxyethyl)-30-(4-hydroxybenzyl)-6-[(1S)-1-hydroxyethyl]-3,21-bis(hydroxymethyl)-27-methyl-9,24-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32,35,38-tridecaoxo-1,4,7,10,13,16,19,22,25,28,31,34,37-tridecaazacyclodotetracontan-15-yl]propyl}amino)methylidene]ammonium | | Formula: | C63 H106 N18 O21 | | Definition date: | 2015-10-28 | | Last modified: | 2015-10-28 |
|
 | | PRD_000841 | | Name: | CARBOXYPROPYL-BETA-THIOGALACTOSIDE-LYS-PRO-LEUNH2 | | Formula: | C26 H48 N5 O9 S | | Definition date: | 2015-09-16 | | Last modified: | 2015-09-16 |
|
 | | PRD_001241 | | Name: | (BOC)LPA(B27) PEPTIDE | | Formula: | C23 H42 N4 O6 S | | Definition date: | 2015-09-09 | | Last modified: | 2015-09-09 |
|
 | | PRD_002106 | | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-4-{[(1S)-1-carboxybutyl]amino}-3-hydroxy-4-oxo-1-(thiophen-2-yl)butan-2-yl]-3-thiophen-2-yl-L-alaninamide | | Formula: | C31 H45 N5 O9 S2 | | Definition date: | 2015-07-29 | | Last modified: | 2015-07-29 |
|
 | | PRD_000815 | | Name: | peptide ACE-THR-VAL-ALC-HIS-H | | Formula: | C26 H43 N6 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2015-07-27 |
|
 | | PRD_001000 | | Name: | peptide ACE-SER-ALA-VAL-LEU-HIS-H | | Formula: | C25 H42 N7 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2015-07-21 |
|
 | | PRD_000990 | | Name: | peptide ACE-SER-ALA-VAL-ALC-HIS-H | | Formula: | C28 H46 N7 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2015-06-29 |
|
 | | PRD_001257 | | Name: | para-guanidinomethyl-phenylacetyl-Arg-(3-methylvaline)-Arg-(amidomethyl)benzamidine | | Formula: | C36 H59 N15 O4 | | Definition date: | 2015-05-27 | | Last modified: | 2015-06-22 |
|
 | | PRD_002174 | | Name: | N-(tert-butoxycarbonyl)-L-seryl-L-valyl-N-{(2S)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-L-leucinamide | | Formula: | C30 H53 N5 O9 | | Definition date: | 2015-06-17 | | Last modified: | 2015-06-17 |
|
 | | PRD_002159 | | Name: | N-(4-methoxy-4-oxobutanoyl)-L-alanyl-L-alanyl-N-[(2S)-4-chloro-3-oxo-1-phenylbutan-2-yl]-L-prolinamide | | Formula: | C26 H35 Cl N4 O7 | | Definition date: | 2015-05-06 | | Last modified: | 2015-05-06 |
|
 | | PRD_002133 | | Name: | (17S,20S,23S,29S)-20-benzyl-29-{[(2S)-2-(methylamino)propanoyl]amino}-19,22,28-trioxo-2,11-dioxa-5,6,7,18,21,27-hexaazapentacyclo[29.2.2.2~12,15~.1~4,7~.0~23,27~]octatriaconta-1(33),4(38),5,12,14,31,34,36-octaene-17-carboxylic acid (non-preferred name) | | Formula: | C42 H50 N8 O8 | | Definition date: | 2015-03-04 | | Last modified: | 2015-03-04 |
|
 | | PRD_001256 | | Name: | bifunctional peptide | | Formula: | C39 H43 N5 O5 | | Definition date: | 2015-01-14 | | Last modified: | 2015-01-14 |
|
 | | PRD_001172 | | Name: | nosiheptide bound form | | Formula: | C51 H53 N13 O12 S6 | | Definition date: | 2014-12-10 | | Last modified: | 2014-12-10 |
|
 | | PRD_001208 | | Name: | Stapled peptide (ACE)NWFNITN(DIV)LW(MK8)I(LYV)KKK | | Formula: | C106 H165 N27 O28 P | | Description: | MODIFIED FRAGMENT OF HIV GLYCOPROTEIN (GP41) | | Definition date: | 2014-12-03 | | Last modified: | 2014-12-03 |
|
 | | PRD_001209 | | Name: | Stapled peptide (ACE)NWFNITN(DIV)LW(MK8)IKKKK | | Formula: | C103 H161 N25 O22 | | Description: | MODIFIED FRAGMENT OF HIV GLYCOPROTEIN (GP41) | | Definition date: | 2014-12-03 | | Last modified: | 2014-12-03 |
|
